Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Research article

Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231

Arturo Aguilar-Rojas12*, Maira Huerta-Reyes1, Guadalupe Maya-Núñez2, Fabián Arechavaleta-Velásco2, P Michael Conn3, Alfredo Ulloa-Aguirre4 and Jesús Valdés5

Author Affiliations

1 Centro de Investigación Biomédica del Sur (CIBIS), Instituto Mexicano del Seguro Social (IMSS), Argentina No. 1, Col. Centro, 62790, Xochitepec, Morelos, Mexico

2 Research Unit in Reproductive Medicine, Unidad Médica de Alta Especialidad-Hospital de Ginecobstetricia No. 4 “Luis Castelazo Ayala” IMSS, Mexico, DF, Mexico

3 Oregon National Primate Research Center, Oregon Health Sciences University, Beaverton, OR, USA

4 Division of Reproductive Health, Research Center in Population Health, National Institute of Public Health, Cuernavaca, Morelos, Mexico

5 Departament of Biochemistry, Centro de Investigación y de Estudios Avanzados (CINVESTAV), Apartado Postal 14-740, Mexico, DF, 07000, Mexico

For all author emails, please log on.

BMC Cancer 2012, 12:550  doi:10.1186/1471-2407-12-550

Published: 23 November 2012

Abstract

Background

Gonadotropin-releasing hormone (GnRH) and its receptor (GnRHR) are both expressed by a number of malignant tumors, including those of the breast. In the latter, both behave as potent inhibitors of invasion. Nevertheless, the signaling pathways whereby the activated GnRH/GnRHR system exerts this effect have not been clearly established. In this study, we provide experimental evidence that describes components of the mechanism(s) whereby GnRH inhibits breast cancer cell invasion.

Methods

Actin polymerization and substrate adhesion was measured in the highly invasive cell line, MDA-MB-231 transiently expressing the wild-type or mutant DesK191 GnRHR by fluorometry, flow cytometric analysis, and confocal microscopy, in the absence or presence of GnRH agonist. The effect of RhoA-GTP on stress fiber formation and focal adhesion assembly was measured in MDA-MB-231 cells co-expressing the GnRHRs and the GAP domain of human p190Rho GAP-A or the dominant negative mutant GAP-Y1284D. Cell invasion was determined by the transwell migration assay.

Results

Agonist-stimulated activation of the wild-type GnRHR and the highly plasma membrane expressed mutant GnRHR-DesK191 transiently transfected to MDA-MB-231 cells, favored F-actin polymerization and substrate adhesion. Confocal imaging allowed detection of an association between F-actin levels and the increase in stress fibers promoted by exposure to GnRH. Pull-down assays showed that the effects observed on actin cytoskeleton resulted from GnRH-stimulated activation of RhoA GTPase. Activation of this small G protein favored the marked increase in both cell adhesion to Collagen-I and number of focal adhesion complexes leading to inhibition of the invasion capacity of MDA-MB-231 cells as disclosed by assays in Transwell Chambers.

Conclusions

We here show that GnRH inhibits invasion of highly invasive breast cancer-derived MDA-MB-231 cells. This effect is mediated through an increase in substrate adhesion promoted by activation of RhoA GTPase and formation of stress fibers and focal adhesions. These observations offer new insights into the molecular mechanisms whereby activation of overexpressed GnRHRs affects cell invasion potential of this malignant cell line, and provide opportunities for designing mechanism-based adjuvant therapies for breast cancer.

Keywords:
Gonadotropin-releasing hormone receptor (GnRHR); Gonadotropin-releasing hormone (GnRH); RhoA GTPase; Cell migration; Cell adhesion; Buserelin